Ether à go-go 1 Silencing in Combination with TRAIL Overexpression Has Synergistic Antitumor Effects on Osteosarcoma-Reference-Cited by-同舟云学术

Ether à go-go 1 Silencing in Combination with TRAIL Overexpression Has Synergistic Antitumor Effects on Osteosarcoma

Published:2013-02 Issue:1 Volume:28 Page:65-70
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Wu Jin¹,Zeng Tian²,Wu Xinyu³,Gao Quan¹,Zhai Wenliang¹,Ding Zhenqi¹

Affiliation:

1. Department of Orthopaedics, The Affiliated Southeast Hospital of Xiamen University, Zhangzhou, People's Republic of China.

2. Department of Anesthesiology, The 323th Hospital of PLA, Xi'an, People's Republic of China.

3. Department of Neurology, The Affiliated Southeast Hospital of Xiamen University, Zhangzhou, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1283

Reference37 articles.

1. Osteosarcoma, Chondrosarcoma, and Ewing's Sarcoma

2. Osteosarkom und Ewing-Sarkom - die häufigsten Knochentumoren bei Kindern: Therapie und Ergebnisse

3. Osteosarcoma

4. Cellular and molecular properties associated with osteosarcoma cells

5. Metastatic Osteosarcoma Presenting as a Small-Bowel Polyp

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies;ACS Omega;2022-06-01

2. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment;Medicinal Research Reviews;2021-05-04

3. Ion channels in sarcoma: pathophysiology and treatment options;Pflügers Archiv - European Journal of Physiology;2019-08-03

4. Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis;Oncology Letters;2018-03-08

5. Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin;European Biophysics Journal;2016-06-27